FOXP3 and lung cancer: FOXP3+ TIL are associated with poor prognosis in most cancers including breast cancer, lung cancer and pancreatic cancer, but in the case of colorectal or gastric cancer, FOXP3+ TIL correlate to improved clinical outcomes (10).